Home
»
Healthcare IT
»
ePharmacy Market Size, Share & Trends Report, 2030

ePharmacy Market Size, Share & Trends Report

ePharmacy Market (2023 - 2030) Size, Share & Trends Analysis Report By Drug Type (Prescription Drug, OTC Drug), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts

Market Segmentation

ePharmacy Drug Type Outlook (Revenue, USD Million, 2017 - 2030)
- Prescription Drug
- Over the Counter Drug (OTC)
ePharmacy Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
  - North America ePharmacy Market, By Drug-type
    - Prescription Drug
    - Over the Counter Drug (OTC)
  - U.S.
    - U.S. ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Canada
    - Canada ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
- Europe
  - Europe ePharmacy Market, By Drug-type
    - Prescription Drug
    - Over the Counter Drug (OTC)
  - Germany
    - Germany ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - U.K.
    - U.K. ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Spain
    - Spain ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Italy
    - Italy ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - France
    - France ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Russia
    - Russia ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Norway
    - Norway ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Sweden
    - Sweden ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Denmark
    - Denmark ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
- Asia Pacific
  - Asia Pacific ePharmacy Market, By Drug-type
    - Prescription Drug
    - Over the Counter Drug (OTC)
  - Japan
    - Japan ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - China
    - China ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - India
    - India ePharmacy Market, By Drug-type
      - Prescription Drug
    - Over the Counter Drug (OTC)
  - Australia
    - Australia ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Singapore
    - Singapore ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - South Korea
    - South Korea ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Thailand
    - Thailand ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
- Latin America
  - Latin America ePharmacy Market, By Drug-type
    - Prescription Drug
    - Over the Counter Drug (OTC)
  - Brazil
    - Brazil ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Mexico
    - Mexico ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Argentina
    - Argentina ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
- MEA
  - MEA ePharmacy Market, By Drug-type
    - Prescription Drug
    - Over the Counter Drug (OTC)
  - South Africa
    - South Africa ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Saudi Arabia
    - Saudi Arabia ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - UAE
    - UAE ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)
  - Kuwait
    - Kuwait ePharmacy Market, By Drug-type
      - Prescription Drug
      - Over the Counter Drug (OTC)

ePharmacy Market Dynamics

Driver: Rising penetration of the internet and shift toward online purchase

The growth of the ePharmacy market can be attributed to the increasing internet penetration worldwide. This surge in internet usage has resulted in a notable shift in consumer behavior towards online purchases. According to the International Telecommunication Union, there were projected to be 3.2 billion internet users globally by the end of 2015. Furthermore, the Digital 2021 July Global Statshot Report revealed that approximately 4.80 billion individuals worldwide were using the internet as of July 2021. Notably, low- and middle-income countries are experiencing substantial growth in internet users, with emerging economies like India and China leading the way. With the continuous improvement of IT infrastructure and the rising number of smartphone users globally, the ePharmacy market is expected to witness significant growth. Internet pharmacies serve as intermediaries between consumers and sellers, gaining popularity due to various advantages such as easy access to medications, competitive prices, attractive discounts, and the convenience of home delivery. As internet penetration continues to expand, along with advancements in high-speed connectivity and the availability of online products and services, the number of individuals purchasing healthcare products online is expected to increase in the foreseeable future. In the rapidly growing healthcare industry, manufacturers and distributors are actively seeking tools that can enhance supply chain management through e-commerce solutions.

Driver: Growing opportunities in emerging economies

Emerging and developing economies are experiencing a surge in online purchases from smartphones and other web-enabled devices. The growth of e-commerce in various sectors can be attributed to improved IT infrastructure in developing nations and increased investments in technology. Additionally, the rising expenditure on healthcare is expected to drive the market in these countries further. However, these economies face challenges such as a rapidly increasing population, changing lifestyles, and a growing burden of health conditions. To address these challenges, there is a pressing need to ensure the availability of quality medicines and expand access to healthcare treatments in remote regions of developing countries. This has led to the adoption of ePharmacy in the healthcare sector, which is still in its early stages but holds significant potential for future growth. The China FDA's approval of online sales of prescription drugs is also anticipated to contribute to the expansion of the market. Furthermore, the increasing number of start-ups in these countries is fueling market growth, with approximately 140 start-ups operating in the online pharmacy market in India, as reported by The Times of India. These start-ups have also received increased financial support and funding. Moreover, the growing presence of online healthcare providers and government support are expected to further propel the market's growth.

Restraint: The presence of a large number of illegitimate online pharmacies

The availability of attractive offers and price discounts has facilitated the proliferation of illegal online pharmacies. Unfortunately, many consumers who purchase medicines online are unaware of the legality of the websites they are buying from. Consequently, there is a constant risk of receiving counterfeit and contaminated medications that may contain incorrect active ingredients or unapproved drugs. A survey conducted by the U.S. FDA among internet users revealed that 29% of online buyers need clarification about the safe procurement of medicines from internet pharmacies, and over 20% of respondents admitted to purchasing prescription medicines online. The World Health Organization (WHO) estimates that counterfeit and substandard medicines amount to approximately USD 431 billion. In January 2016, the National Association of Boards of Pharmacy (NABP) released a report called the Internet Drug Outlet Identification Program Progress Report, which highlighted that in 2015, more than 10,668 internet drug outlets were identified as "Not Recommended" by the NABP. These websites do not provide a listed location and offer medicines that are either not approved by the U.S. FDA or are foreign drugs. The report also revealed that 90% of these websites appear to have some affiliation with rogue networks of internet drug stores. However, the U.S. FDA has launched a public education campaign to raise consumer awareness about the risks associated with purchasing medicines online. This campaign is expected to help reduce the dangers related to online medicine purchases.

What Does This Report Include?

This section will provide insights into the contents included in this ePharmacy market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

ePharmacy market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments